Clinical Trial

Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health

Study acronym: TIMET 2
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
In a randomized controlled trial, the investigators intend to measure the health impact of time restricted eating (TRE) in patients with metabolic syndrome (with elevated blood pressure and at least 2 of the following: increased waist circumference, abnormal cholesterol levels, elevated triglycerides, and elevated fasting glucose levels), who habitually eat more than 12 hours every day. Patients will be randomly assigned to a control group (standard of care) or intervention group (TRE).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-16; most recent amendment 2026-01-29.
Trial Details
NCT Number NCT07189234
Lead Sponsor University of California, San Diego
Collaborators: Salk Institute for Biological Studies
Conditions Metabolic Syndrome, Pre-diabetes
Enrollment 140 participants
Start Date 2025-10-23
Primary Completion 2028-07-06 (estimated)
Study Completion 2029-01-06 (estimated)
Updated on ClinicalTrials.gov 2026-02-02